A pioneer in gene therapy and cancer research
Alan Bernstein is a world renowned health leader, researcher and mentor. His published work on the KIT gene is classic, still cited often, and is the basis for important advances in cancer therapy. Dr. Bernstein completed his PhD at the University of Toronto and completed postdoctoral research in London at the Imperial Cancer Research Fund, where he first began working on retroviruses. Since his return to Canada, he has continued to make important contributions to cancer and stem cell research as well as advanced studies into a vaccine for HIV. In addition to his scientific contributions, Dr. Bernstein has held important leadership positions in the field of health research. In the process, he has transformed the vision of what health research should look like.